ArticleJournal of virology2004

Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro.

Kenji Maeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.